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Abstract. Expression of the Q5 k gene was examined by 
northern blot analysis and polymerase chain reaction 
(PCR) in the AKR mouse and various cell lines, each of 
the H-2 ~ haplotype. Our results show that Q5 k mRNA is 
present during the whole postimplantational development 
of the AKR embryo/fetus (gestation day 6 to 15). In the 
juvenile mouse (week 2 to 4) transcription of the Q5 ~ 
gene persisted in all organs examined. In contrast, in the 
adult animal expression of the Q5 ~ gene was limited to 
the thymus and uterus of the pregnant mouse. Upon malig- 
nant transformation, the amount of Q5k-specific mRNA 
increased dramatically in thymus and could also be 
observed in the spleen of thymoma bearing animals. Ex- 
pression of the Q5 k gene was also detectable in several 
transformed mouse cell lines. Mitogen stimulation or 
treatment with cytokines induced Q5 k expression in 
primary spleen cell cultures. A possible explanation for 
the tissue-restricted xpression i  the adult AKR mouse 
is discussed. 
Introduction 
The majority of the mouse major histocompatibility com- 
plex (Mhc) class I genes are encoded by the Q/TL region, 
localized telomeric to the H-2 complex. Both the Q and 
TL subregions vary significantly among different inbred 
mouse strains. The Q region contains between one and 
ten loci (Weiss 1987). Class I gene products of this region 
are similar to the H-2K antigen in respect of nucleofide 
homology, antigenic crossreactivity, association with 
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32-microglobulin, and peptide structure (Michaelson et 
al. 1977; Stanton and Hood 1980; Soloski et al. 1981; 
Klein 1986). However, the Q genes differ from classical 
transplantation genes, which function as restriction 
elements for cytotoxic T lymphocytes, in several respects. 
Unlike the classical class I antigens all of which are 
transmembrane proteins, the Q region products are found 
in two different forms: as secreted molecules (Kress et 
al. 1983; Devlin et al. 1985a) and as cell surface molecules 
anchored in the membrane via phosphatidylinositol (PI) 
linkage (Stiernberg et al. 1987; Stroynowski et al. 1987; 
Waneck et al. 1988). In addition, their expression is 
limited to only a few tissues of hematopoietic origin. Com- 
pared with the highly polymorphic H-2 alleles, the Q 
region genes display no polymorphism (Steinmetz et al. 
1981; Mellor et al. 1984; Devlin et al. 1985b; Klein 1986; 
Weiss 1987; Flaherty et al. 1990; Tine et al. 1990). 
The exact function of genes mapping to the Q/TL 
region, or that of the gene products is so far unknown, 
and there is little information available on their expression 
pattern in adult and embryonic tissues (Fahrner et al. 
1987). It seems to be evident, however, that T-cell recep- 
tor (Tcr) 3,6-positive T lymphocytes can recognize 
nonclassical c ass I antigens of the TL region (Haas et al. 
1990; Ito et al. 1990), possibly induced by transformation 
and infection (Janeway et al. 1988). 
The Q region of the AKR (H-2 k) mouse is comprised 
of six genes: Q1 k, Q2 k, Qfi, Q4 k, Q5 k, and QIO k with the 
Q5 gene being directly linked to the QIO gene (Weiss et 
al. 1989). The organization and structure of the AKR-Q 
family is therefore virtually identical to the Q genes of 
the C3H (H-2 k) mouse (Watts et al. 1989). The Q5 k gene 
of the AKR mouse has some unique features: It codes for 
a classical transmembrane domain almost identical to the 
hydrophobic membrane anchor of the H-2D d gene, and 
thus, it should etermine an integral cell surface glycopro- 
rein. Since the unique restriction map of the AKR Q5 k 
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gene points to the absence of a direct counterpart in the 
C57BL/10 haplotype, this gene might constitute the first 
polymorphic lass I gene localized in the Q region. 
To further elucidate the biological and functional role 
of the Q5 ~ gene, it is essential to first investigate the ex- 
pression of this gene in the AKR mouse. Therefore, we 
studied the expression of the Q5 k gene in a wide spec- 
trum of different juvenile and adult AKR tissues, primary 
tumor, tissue, and tumor, respectively tumor producing 
cell lines and one embryonic ell line. In addition, we 
focused on the developmentally regulated activation 
in postimplantation mouse embryos. A regulational 
mechanism possibly responsible for restricted Q5k-ex - 
pression in the adult animal was also studied. 
Materials and methods 
Cell culture. The high tumor producing (sarcoma) cell line NCTC 2472 
(ATCC CCL 11, derived from connective tissue culture of a male 
C3H/HeN mouse) and low tumor producing cell line NCTC 2555 
(ATCC CCL 12, derived from connective tissue of a male C3H/HeN 
mouse), the mouse lymphoma cell line RI.I (ATCC TIB 42, derived 
from a spontaneously arising thymoma of a C58/J mouse, H-2k), the 
embryonic cell line C3H/10T1/2 (ATCC CCL 226, derived from a line 
of C3H mouse embryo cells), the AKR-derived spontaneous leukemia 
cell lines 110, 339, 344, 365, 369, 389,422, 424, and 439 (AKR-cell 
lines, originally established by P. Kramer, Heidelberg, were obtained 
from W. Schmidt, Essen), and the human Jurkat T-cell line were main- 
tained in RPMI 1640 or Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10 % fetal calf serum (FCS; Gibco-BRL, Eggenstein, 
FRG). Mouse spleen cell cultures were grown in RPMI 1640 sup- 
plemented with 10% FCS, 2 mM L-glutamine, and 5 x 10-SM/3-mer- 
captoethanoI. For the stimulation of the mouse cell lines recombinant 
mouse IFN-3, (Genzyme, Boston, MA) was used at a final concentration 
of 100-1000 U/mi, and recombinant murine IFN-a//3 (Genzyme) at a 
final concentration of 250 U/mi (for 6, 12, and 24 h). Phytohemag- 
glutinin (PHA; Sigma, Deisenhofen, FRG) at a final concentration f
2 Ixg/ml, lipopolysaccharide (LPS; Sigma) at a final concentration f
1 gg/ml, and Concanavalin A (ConA; Sigma) at a final concentration 
of 2.5 gg/ml were used for the stimulation of mouse spleen cells. 
The Jurkat cell line was stimulated with PHA at a final concentration 
of 10 gg/ml, and with PMA at a final concentration of 50 ng/mi. 
Embryonic material. Spontaneously ovulating female Balb/c (H-2 d) 
mice were caged with AKR (H-2 ~) males overnight and examined for 
the presence of a vaginal plug the following morning. The day of plug 
detection was taken as day 0 of embryo development and the approximate 
age of embryos calculated accordingly. Pregnant females (obtained from 
two animal facilities) were killed by cervical dislocation and several 
stages of embryonic development from postimplantation pregnancy were 
examined. Entire conceptuses were dissected from the decidual shells 
of the 6-, 8-, 9-, 10-, 14-, and 15-day pregnant mouse uterus and placed 
in Dulbecco's modified Eagle's medium (DMEM) with 10 % FCS. Con- 
ceptuses from day 14 on were dissected into extra-embryonic t ssues 
and embryo proper, 15-day embryos were dissected in embryonic liver, 
the main hematolymphopoietic organ, and body trunk. Immediately after 
dissection, embryos were frozen and kept at a temperature of -70  °C 
until RNA preparation was performed. 
Northern blot analysis. Total RNA from embryonic tissues, adult 
tissues, and cell lines was prepared according to the guanidinium thio- 
cyanate procedure as described by Chlrgwin and co-workers (1979) and 
by sedimentation through a cesium chloride gradient. Alternatively, 
RNA from cell cultures was isolated by acid guanidinium thiocyanate- 
phenol-chloroform extraction (Chomczynski and Sacchi 1987). Poly 
(A) + RNA was purified by oligo (dT) cellulose chromatography. 
10-20 ~tg total RNA or 1 [.tg poly (A) + RNA were separated on for- 
maldehyde/1% agarose gels and then transferred to Hybond-N mem- 
branes (Amersham, Braunschweig, FRG). 
Restriction fragments. The 3' and 5' Barn HI fragments of the D b gene 
(Weiss et al. 1984); human 1.6 kilobase (kb) actin cDNA; murine 132m 
cDNA (Morello et al. 1982); /32m has been shown to be synthesized 
even in early cleavage stage mbryos (Sawicki et al. 1981) were labeled 
according to Feinberg and Vogelstein (1984) and hybridization and 
washing of the filters were performed following standard protocols 
(Church and Gilbert 1984). Purification of the Q5*- (derived from exon 
4 of the Q5 ~ gene, Fig. 7B), the K k- (TGGCGATCTGCGTGTTCC, 
derived from exon 2 of the K k gene), and the D k- (TTCAACTT- 
TAGATCTGGGGTGAT, derived from exon 4 of the D k gene) 
oligonucleotides and hybridization ata temperature of 60 o C for the Q5*- 
and D k-, respectively 55 °C for the Kk-oligonucleotide was done as 
described by Cate and co-workers (1986). The probes were labeled with 
terminal desoxynucleotidyl transferase (Boehringer Mannheim, Mann- 
heim, FRG) and ~3ap-dATP (Amersham; Collins and Hunsaker 1985). 
Washing was done at hybridization temperature with 3 x standard 
sodium citrate (SSC), 10 mM NaH2PO4/NazHPO4, 5% sodium dodecyl 
sulfate (SDS) for 2 x 20 min and with 1 x SSC, 1% SDS for 20 min. 
The Kk-oligonucleotide is specific for the K k gene, since it does not 
hybridize to liver RNA isolated from a Balb/c (H-Y) mouse and also 
gives no signal with cell line 422, shown ot to transcribe the endogenous 
K k gene (Fig. 6). The Dk-oligonucleotide was shown to be Dk-specific 
by hybridization to isolated AKR class I genes and to liver RNA of 
various inbred mouse strains (data not shown). 
Reverse transcription (RT) and polymerase chain reaction (PCR). RNA 
was transcribed into cDNA by the following standard reaction. The listed 
reagents were dispensed 0 °C into a microcentrifuge tube: 10 Ixl of 
5 x M-MLV reverse transcriptase (RT) buffer (250 mM Tris/HC1, pH 
8.3,375 mM KC1, 50 mM DDT, and 15 mM MgC12); 1 gl (5 gg/Ixl) 
of nuclease free borine serum albumin (BSA), 2.5 gl of nucleotide solu- 
tion (10 mM each of dATP, dGTP, dCTP, dTTP in 10 mM Tris/HC1, 
pH 7.5), 5 gl RT-primer (100 pM), 1-2 ~tg of heat denatured RNA in 
sterile destilled Hat  , sterile destilled Hat  to 49 ~tl, and 1 gl of M- 
MLV RT (BRL: Darmstadt, FRG, 200 U/gl.) The reverse transcription 
assay was incubated at 37 °C for 1 h. Standard PCR was performed 
as described by Saiki and co-workers (1988). A portion of the RT-reac- 
tion (5 gl) was mixed with 1 unit of Taq polymerase (8 units/gl, US 
Biochemicals, OH), 5' and 3' sequence specific oligonucleotide primers 
(0.4 ~tM), nucleotide solution (0.1 mM each of dATP, dGTP, dCTP, 
dTTP) in a buffer containing 10 mM Tris/HCl, pH 8.4, 1 mM MgC12, 
50 mM KC1 in a 50 pA volume. The mixture was overlaid with mineral 
oil to prevent evaporation, and after denaturation (95 °C, 5 min) 30 
cycles of amplification were carried out on a programmable h ating 
block (Biometra, Gtttingen, FRG), followed by 10 min final extension 
at 72 °C (temperature profile for the Q5 k amplification: 94 °C - 1 rain 
denaturation, 62 °C - 1 min annealing, 72 °C - 1 min extension). 
Booster PCR was performed as described by Ruano and co-workers 
(1989). In this biphasic amplification strategy primers were diluted to 
low concentrations (pM) during the first amplification step, and then 
raised to 0.1 gM at the beginning of the second round of amplification. 
A portion of the PCR mixture (10-15 gl) was added to a loading dye 
mix and electrophoresed in a 80 V constant field in 2% agarose gels. 
DNA separated on agarose gels was transferred to Hybond-N + mem- 
brane (Amersham). The filters were hybridized with the QS~-specific 
Q5*- oligonucleotide as described. 
RTprimer. CCACCTGTGTTTCTCCT, spanning exon 5 and 6 of the 
Q5 k gene. Q5k-amplification primer: 5'-primer (Q5 I): ATGTGTGAA- 
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GAGGCTCCTGGAT, derived from exon 3 of the Q5 k gene, 3'-primer 
(Q5 II): GTGTTAGTCTTGGTGGATGAAG, derived from exon 5 of 
the Q5 k gene (Fig. 7B). 
Electrophoretic mobility shift assay (EMSA). Stimulated phytohemag- 
glutinin (PHA 5 ~tg/ml, TPA 50 ng/ml, for 4 h) and nonstimulated Jurkat 
T-cells were harvested, washed in ice-cold phosphat-buffered solution 
(PBS), and then lysed in hypotonic buffer A (Dignam et al. 1983). 
Nuclear and cytosolic fractions were prepared as described (Baeuerle 
and Baltimore 1988). Annealed DNA-primers were labeled with o32P - 
dATP (Amersham) by the Klenow enzyme (Boehringer Mannheim), and 
then electrophoretically purified on 3 % low melting agarose gels, ex- 
tracted with Tris (TE) EDTA saturated phenol, followed by 
chloroform/isoamylalcohol (24:1) extraction, precipitation, and finally 
dissolved in 10 mM Tris/HC1, pH 7.5, 0.5 mM ethylenediaminetetra- 
acetate (EDTA). Conditions for electrophoretic mobility shift assays 
were essentially as described by Sen and Baltimore (1986). The purifica- 
tion of NF-kB from human placenta is described by Zabel and co- 
workers (1990), the isolation of p50 and p65 from affinity-purified NF- 
kB by SDS-gel electrophoresis and subsequent renaturation is described 
by Baeuerle and Baltimore (1989). The amounts of the two DNA-binding 
forms of NF-kB were calculated from the amount of protein-DNA com- 
plex, which was formed in EMSAs with a DNA probe of known specific 
activity under saturating concentrations of DNA. The sequences used 
for the investigations are: A (Fig. 8): Q5 ~ motif (Q): 5'AGCTT- 
CCCAGGGCTAGGGATTCCCCATCTCCCCAG3', HLA-A2 motif 
(A2): 5'AGCTTCCCAGCCTTGGGGATTCCCCAACTCCGCAG3', 
ld3 motif (kb): 5'TCTGAAGCTTCAGAGGGACTTTCCGAGAGGT- 
CGA3' (Sen and Baltimore 1986); minimal binding site in the center. 
B (Fig. 9): Q5 ~ motif: 5'TCGAGGGCTAGGGATTCCCCATCT3', 
H-2K ~ motif: 5'TCGAGGGCTGGGGATTCCCCATCT3'. 
Results 
Expression of  the Q5 k gene in the juvenile and adult AKR 
mouse. Investigation of tissue expression of the Q5 k gene 
was performed using the previously described Q5 k- 
specific Q5*-oligonucleotide (Weiss et al. 1989). This se- 
quence is unique to the Q5 gene encoded by H-2 ~ 
haplotypes. Total RNA preparations of different organs 
from two, three, and four week old and adult (ten weeks 
or older) AKR mice were tested by northern blot analysis. 
Control hybridizations were carried out with a mouse 
class I probe [either the 3' or 5' Barn HI fragments of the 
D b gene or with the Kk-specific oligonucleotide (Kk)]. In- 
tegrity and amount of mRNA applied was determined by 
hybridization with an actin or a Be-microglobulin probe. 
While constant and low levels of the Q5 k message 
were observed inthe heart, liver, and spleen of two, three, 
and four week old AKR mice (Fig. 1, lanes 1 to 8), in 
the thymus, Q5 k mRNA level dramatically increased 
from week 2 to 3 (Fig. 1, lanes 9 to 11). 
Adult AKR tissues could be divided into two groups: 
tissues without detectable Q5 k expression (lung, liver, 
heart, kidney, uterus, and skeletal muscle) and tissues 
with Q5 k expression (uterus of the pregnant animal, 
three animals of different pregnancy duration were tested; 
thymus; thymomas, isolated from two animals; spleen of 
the animals with thymomas; Fig. 2). Even after over-ex- 
posure no signal was detectable in negative tissues. 
Notably, the highest levels of Q5 k message were detected 
in the thymomas and spleen cells of adult AKR mice with 
thymomas (Fig. 2, lanes 3, 4, and 12). 
Q5 k gene expression in mouse cell lines. The high level 
of Q5 k mRNA in the primary AKR thymomas led us to 
investigate Q5 k transcription in cell lines established 
from primary AKR leukemias (cell lines 110, 339, 344, 
365,369,'389,422,424, and 439; Fig. 3). The level of 
K k mRNA correlated with the even lower amount of D k 
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Fig. 1. Detection of Q5 k mRNA in different organs 
(heart, liver, spleen, and thymus) of juvenile AKR mice 
(week 2 to 4). 8-12 gg of total RNA were probed 
with the Q5*-oligonucleotide (upper panel). Ethidium 
bromide staining of the 28S is shown in the lower panel. 
Liver RNA isolated from an adult BALB/c (1-1-2 d) 
mouse (lane 13) was applied as negative control. RNA 
isolated from adult AKR splenocytes ( timulated with 
PHA) was loaded as positive control (lane 12). 
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Fig. 2. Expression of the Q5 k gene in tissues of adult AKR mice. 8-12 
gg total RNA isolated of thymus, heart, liver, skeletal muscle, kidney, 
uterus, and spleen was probed with the Q5*-oligonucleotide (upper 
panel); in the lowerpanel ethidium bromide staining of the 28S is shown 
as control of the amount of RNA applied. In addition to normal AKR 
tissue, primary thymoma (isolated from two different animals; lane 3 
and 4), spleen tissue removed from one of the animals with thymoma 
(**, lane 12), and uterus from one pregnant animal (*, lane 10) were 
also tested for Q5 k expression. 
'w- ~') ¢~" tO (,0 ¢0 ¢'4 ¢q ¢'~ 
Q5 k 
K k - -  
D k - -  
1 2 3 4 5 6 7 8 9 
Fig. 3. Expression of the Q5 k, H-2I~, and H-2D k genes in AKR 
leukemic cells. 10 ~tg total RNA per lane was tested by northern blot 
analysis with the Kk-oligonucleotide (middle panel). After removal of 
the probe the filter was rehybridized with the Dk-oligonucleotide (lower 
panel), and finally with the Q5*-oligonucleotide (upper panel). 
transcripts (see Fig. 3, compare cell lines 339,369,424). 
This result is in agreement with the previously observed 
H-2K k and H-2D k cell surface xpression (Schmidt et al. 
1985), but no correlation was found with regard to the 
amount of Q5 k mRNA detected in these AKR leukemias. 
Additional tumor, respectively tumorigenic cell lines, and 
one embryonic ell line derived from different mouse 
strains each of the H-2 ~ haplotype were also tested (RI.I, 
NCTC 2472, NCTC 2555, and C3H; Fig. 4). Northern 
blot hybridizations with the Q5*-oligonucleotide revealed 
that the Q5 ~ gene is transcriptionally active in all these 
cell lines, with the highest mRNA level detectable in the 
actin- 
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Fig. 4. Northern biot analysis of total RNA (8-12 ~tg per lane) from 
different mouse cell lines (lane 2 to 6). The filter was first hybridized 
with the Q5*-oligonucleotide (upper panel), then rehybridized with a 
class I probe (middle panel), and finally with an actin probe (lower 
panel). RNA of the baby hamster kidney cell line (BHK, lane 1) was 
used as negative control for the class I hybridization. 
AKR leukemia cell lines, and the low tumor producing 
cell line NCTC 2555, followed by the lymphoma cell line 
RI.I, the high tumor producing cell line 2472, and the em- 
bryonic cell line C3H. In addition, L929 cells were also 
shown to express the Q5 k gene (data not shown). 
To investigate whether transcription of the Q5 k gene 
could be induced in spleen cells and augmented in the 
tested mouse cell lines, AKR splenocytes and the cell lines 
422 and NCTC 2555 were stimulated with mitogens or 
cytokines. A uniformly weak induction of the Q5 k gene 
expression was detected in primary spleen cell cultures 
treated with Con A or PHA for 48 h, or LPS for 24 h 
compared to the high increase of class I mRNA (Fig. 5). 
In the NCTC 2555 cell line recombinant mouse IFN-3, or 
-~//3 increased Q5 k message, with the highest increase 
observed after IFN-q, treatment (Fig. 5, lane 10, 12 h- 
stimulation). 
Expression of  the Q5 k gene in postimplantation embryos. 
We also focused on the expression of the Q5 k gene dur- 
ing embryonic development, whereby we concentrated 
our investigation on postimplantational development. 
Because contamination of the embryonic tissue with 
maternal material cannot be avoided in early postimplan- 
tation stages, we chose BALB/c (H-2 d females) X AKR 
(H-2 k males) F I embryos (generated by two separate 
breeding facilities) four our study. To determine the onset 
of Q5 k gene transcription, embryos from day 6 (egg 
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Fig. 5. Stimulation of Q5 k expression i AKR spleen cell cultures and 
transformed mouse cell lines. For northern blot analysis 12-15 gg total 
RNA was tested with the Q5*-oligonuleotide (upper panel), and in a 
second step the same filter was rehybridized with both, an actin and 
a class I probe (marked in the middle and lower panel). Splenocytes of 
the AKR mouse were tested either unstimulated (lane 2) or stimulated 
with Con A, PHA, LPS (lane 3 to 5). Cell lines were stimulated with 
IFN-'y (422, lane 7; NCTC 2555, lane 10) or IFN-c~//3 (only shown for 
NCTC 2555, lane 9) for 12 h. Lane 1: total RNA of BHK. 
Poly (A) + 
I o o I 
cylinder stage) to day 15 of gestation were examined. 
Preparations of both total (material from gestation day 6 
to 15) and poly (A) + (material from gestation day 8, 9, 
10, and 14) RNA were tested by northern blot analysis. 
A faint band at 1.6 kilobase (kb) was detectable only in 
poly (A) + RNA preparations from day 8 and older em- 
bryos (Fig. 6). 
A second approach was used to study th onset of 
transcription of the Q5 k gene. Total RNA from em- 
bryonic material of gestation day 6 on was used to prepare 
single stranded eDNA, which provided the substrate for 
specific amplification of part of the Q5 k sequence by 
PCR. We employed the booster PCR procedure, since 
only a few template copies might be present in the early 
postimplantation tissue. Probing the reaction products 
with the Q5*-specific oligonucleotide r vealed that all 
tested embryonic postimplantation stages and tissues ex- 
pressed the expected 372 base pair (bp)-Q5 k product 
(Fig. 7A). These results prove that Q5 k message is pre- 
sent even in embryos from day 6, although it was not 
detectable by northern blot analysis of total cellular RNA. 
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Fig. 6. Q5 k expression i  postimplantation embryos. 1 ~g poly (A) + 
RNA was isolated from F1 embryos (BALB/c/AKR) of gestation day 
8, 9, 10, and 14, and 15 pg total RNA from cell lines 422 and K18 
(Q5k-BHK-transfectant clone; Weiss et al. 1989) were first probed with 
the K k specific oligonucleotide (middle panel), then rehybridized with 
the Q5*-oligonucleotide (upper panel), and finally hybridized with the 
/32m probe (lower panel). 
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Fig. 7 A, B. Detection of Q5 k transcripts mpostimplantation embryos. 
A Amplification products were separated on 2% agarose gels, trans- 
ferred to Hybond-N + membranes, and hybridized with the Q5*-oligo- 
nucleotide. RNA of 6, 8, 9, 14 day embryos was tested (lane 3 to 6) 
and 15 day embryos were dissected into body trunk and liver (lane 7 
and 8). Splenocytes stimulated with phytobemagglutinin (PHA; Fig. 5) 
and Balb/c liver RNA were analyzed accordingly as positive and 
negative control (lane 1 and 2). In all lanes (except the negative control) 
the amplification product of the expected size of 372 bp hybridized with 
th Q5*-oligonucleotide. B Total RNA of embryonic material was reverse 
transcribed into eDNA priming with a class I specific RT-primer, 
followed by a QSk-specific booster PCR (Q5I, Q5II). 
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5".210 TCCAGGCGGTGAGGTCAGGGGTGGGGAAGCCCAGGGCTAG GGATTCCCCA]TCTCCCCAG1TFCACI~I~GCTCCTG RE I -135 3" 
-195 Class I regulalory e~ement -1~1 ICS  
I -167 II~N Consensus Sequence -139 
/ \ 
O 5 k TAGGGATTCCCCA 
Q10 TGAGGACTCCCCA 
Q7 b TG GGGAi-FCCCCA 
H-2K b TGGGGA't-fCCCCA 
H-2L d TGGGGA'i-I'CCCCA 
H-2D d TGGGGA'~'CCCCA 
HLA-A2 TGGGGA'i-FCCCCA 
Fig. 8 A. Interaction of NF-kB and 
H2TF1/KBF1 with the Q5 k regulatory se- 
quence: Analysis of nuclear factor binding 
using an electrophoretic mobility shift 
assay. Radioactively abeled Q5k-probe 
(Q), respectively HLA-A2 (A2) probe, be- 
ing sequence identical to H-2K b for the 
binding region, were incubated with 
nuclear (N) or cytosolic (C) extracts of 
either stimulated (+) or unstimulated ( - )  
Jurkat cells, as indicated. The binding 
reactions contained either no competitor 
DNA (lane 1-4, right panel) or increasing 
excess (2.5, 25, 250 molar) of the unla- 
beled Q5 k oligonucleotide (lane 4-6, left 
panel; lane 5-7, right panel), A2 
oligonucleotide (lane 1-3, lefipanel; lane 
8-10, right panel), kB oligonucleotide 
(lane 11-13, right panel), unrelated 
oligonucleotide (unr), derived from the 
plasmid pKK 223-3 (Pharmacia Freiburg, 
FRG), encompassing 56 bp upstream ofthe 
Eco RI site of the polylinker. The thick ar- 
row indicates the position of the specific 
protein-DNA-complex formed with NF- 
kB. The thin arrow indicates the position 
of the specific protein-DNA-complex 
formed with KBF1/H2TF1. B Comparison 
of the CRE sequences of different Mhc 
class I genes revealed that he Q5 k gene 
exhibits anucleotide exchange localized in 
the palindrome sequence (G-A), a site 
which is normally conserved in the pro- 
moter of classical class I genes of mouse 
and human: H-2K b, H-2L d, H-2D ~, Q7 b, 
and HLA-A2 (Kimura et al. 1986; Korber 
et al. 1987; Devlin et al. 1985; Zachow and 
Orr 1989). 
Regulation of  Q5 k expression. Extensive studies on the 
regulation of class I expression have confirmed the impor- 
tant role of a 13 bp palindromic sequence localized within 
the class I regulatory element (CRE) which is conserved 
in mouse and human. This upstream promoter element is 
required for constitutive (KBF1/H2TF 1; Baldwin and 
Sharp 1987; Israel et al. 1987; Yano et al. 1987) as well 
as inducible (NF-kB; Baldwin and Sharp 1988; Israel et 
al. 1989) class I expression. 
Comparison of CRE sequences revealed that the Q5 k 
gene has a mutation (a G to A exchange), localized in the 
core binding site (Fig. 8B), which might explain the lack 
of constitutive expression. Using electrophoretic mobility 
shift analysis, we therefore investigated whether this 
single bp exchange influences nuclear factor binding to 
the CRE of the Q5 k gene. Nuclear extracts from 
stimulated Jurkat T cells were used, which as previously 
shown contain both regulatory proteins, NF-kB and 
KBF1/H2TF1 (Messer et al. 1990). One prominent com- 
plex was formed when the Q5 k motif fragment was in- 
cubated with the extract of stimulated Jurkat cells, but no 
complexes were detected using extracts from unstimulated 
Jurkat cells (Fig. 8A). Formation of the labeled complex 
(thick arrow) was abolished by adding an excess of 
unlabeled Q5k-oligonucleotide, indicating that this com- 
plex is due to the binding of a sequence-specific actor. 
To test whether the interacting factor of the stimulated 
cells is NF-kB, competition analysis was performed with 
the k-immunoglobulin enhancer DNA NF-kB motif. In- 
creasing amounts of this kB-probe, as well as the NF-kB 
binding sequence of the H-2Kb/HLA-A2 (Messer et al. 
1990) genes inhibited complex formation by the radioac- 
tively labeled Q5 k probe. An unrelated DNA probe in 25 
and 250 molar excess had no effect on the binding. The 
comigration of the Q5 k specific complex with well 
characterized shifted bands obtained with NF-kB binding 
sequences (kB/A2), and the fact that this factor is only 
present in stimulated Jurkat cell might indicate that the 
Q5k-motif specifically binds to the NF-kB transcription 
factor, though with a lower affinity than the kB/A2 motifs. 
No additional specific complex was observed with the 
Q5 k motif using extracts of unstimulated or stimulated 
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Jurkat cells, which would indicate the interaction with 
KBF1/H2TF1. The H-2Kb/HLA-A2 probe, however, 
presented two distinct DNA binding activities, NF-kB in 
addition to KBF1/H2TF1 (thin arrow), interacting with 
the conserved palindromic sequence. 
In order to confirm the results obtained with cell ex- 
tracts, demonstrating that the Q5 ~ motif does not interact 
effectively with KBF1/H2TF1, but can still bind NF-kB, 
we used purified NF-kB (heterotetramer, p502 p65z) and 
purified KBF1/H2TF1 (p502, the dimeric form of the 
NF-kB DNA binding subunit (Kieran et al. 1990)) for gel 
shift analysis (Fig. 9). Compared to a homologous com- 
petition with the unlabeled H-2I~/HLA-A2 motif, the 
Q5 k motif had a much lower efficiency to inhibit binding 
of KBF1 than of NF-kB to the labeled H-2Kb/HLA-A2 
motif. These results show that the Q5 ~ sequence has a 
significantly reduced affinity for the binding of 
p502/KBF1, whereas it still binds effectively to p502 
p652/NF-kB. This might explain why only NF-kB was 
detectable with the Q5 ~ probe in nuclear extracts from 
Jurkat cells. 
Discussion 
Transcription of H-2 class I genes is developmentally 
regulated. The status of expression of these genes on 
preimplantation mouse embryos remains controversial 
and it is not clear yet whether the failure to detect H-2 
antigen reflects a true absence of these determinants or
is caused by the limited sensitivity of the techniques 
employed (Searle et al. 1976; Webb et al. 1977; Sawicki 
et al. 1981). Some recent data point to a start of class I 
transcription i the preimplantation embryo (Morello et 
al. 1985). On postimplantation stages, however, H-2 class 
I gene expression is clearly detectable (Morello et al. 
1985; Ozato et al. 1985; Fahrner et al. 1987). 
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Fig. 9 A, B. Competition binding analysis. 
A Purified NF-kB and KBF1 were incubated with 
a 32p-labeled DNA probe encompassing the 13 
bp palindrome of the class I gene H-2K b. Con- 
trol: lane 1. Increasing amounts of oligonucleoti- 
des with the same motif (lane 2 to 5) or the Q5 k 
motif (lane 6 to 9) were incubated with the labeled 
probe. Filled arrowhead indicates the position of 
the protein-DNA-complex formed with KBF1 
(left panel) or NF-kB (right panel), The open ar- 
rowhead indicates the position of the labeled 
H-2K ° probe. B Quantitation of competition effi- 
ciencies. The amount of radioactive protein- 
DNA-complex obtained in the presence of 
unlabeled competitor oligonucleotides is plotted 
as percentage of the control. 
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In this study we were able to detect Q5 k message in 
embryos of gestation day 6 and onward. The fact that we 
were studying the situation in embryos growing in vivo 
and the usage of the highly sensitive RT-PCR technique 
might explain the detection of Q5 k transcripts in embryos 
of gestation day 6 and 8, while Ozato and co-workers 
(1985), showed detectable vels of class I mRNA only 
after midsomite stage on gestation day 9 and older em- 
bryos (C3HxBalb/c, F1). By hybridization with a 
H-2K k specific oligonucleotide, Kk transcripts were 
reproducibly found in eight day embryos, a result which 
has also been described by Fahrner and co-workers (1987) 
for 8.5 day embryos using RNAse protection analysis. By 
S1 nuclease mapping (Morello et al. 1985) detected H-2D d 
mRNA even in preimplantation embryos (blastocysts). 
Thus, it is likely that Q5 ~' activation might also take place 
even before implantation of the embryo. 
Only low levels of classical class I message and sur- 
face antigen are detectable in embryos, but their expres- 
sion increases dramatically during the first weeks of 
postnatal development. In contrast, the Q5 k gene, which 
is expressed at low but almost equal rates in all examined 
juvenile tissues (week 2 to 4), is inactivated in the adult 
AKR mouse with the exception of the thymus. Although 
not examined in detail, overall tissue expression of the 
Q5 k gene in the juvenile AKR mouse is probably a con- 
tinuation of embryonic and fetal Q5 k gene expression. 
Thus, the Q5 k gene might be transcribed in nearly every 
embryonic tissue and stage of development, like the Q7 
and Q9 genes, but in contrast to QIO (Fahrner et al. 1987). 
This Q gene, encoding a class I protein secreted by the 
adult liver, apparently retains its tissue specificity 
throughout embryonic development. 
In the adult AKR mouse Q5 k gene expression is 
clearly tissue restricted. All tested organs are negative for 
Q5 ~ message, except he thymus. Because of multiple 
retroviral insertions adult AKR mice often develop 
tumors, particularly thymomas. Tumor cells frequently 
show quantitative orqualitative alterations in their expres- 
sion of class I molecules which is discussed to be a selec- 
tive advantage for tumor progression (Jones and Bodmer 
1980; Festenstein and Schmidt 1981; Schmidt and 
Festenstein 1982; Lampson et al. 1983; Doyle et al. 1985; 
Schmidt et al. 1986). In particular, AKR derived leukemic 
T-cell lines have been shown to express new H-2 class 
I specificities (Labeta et al. 1989). Notably, the highest 
levels of Q5 k mRNA are found in AKR thymomas and 
also in all established AKR leukemia cell lines studied. 
Therefore, while classical class I antigen expression is
often reduced or even absent (K k- and D k- expression i  
some AKR leukemias (Fig. 3; Henseling et al. 1990), and 
in primary AKR thymomas (data not shown) Q5 k expres- 
sion seems to be augmented in the transformed tissue 
respectively cell lines. Thus, the Q5 k gene product might 
represent he novel H-2 class I "al lo" specificity, 
characterized by Labeta and co-workers (1989) on Q5 ~ 
expressing tumor cell lines. Furthermore, Q5 k expres- 
sion is not restricted to these AKR leukemia derived cell 
lines, Q5 k message is also detectable in other transform- 
ed and tumor producing cell lines. 
Since Q5 ~ mRNA was not detectable in normal adult 
tissue we examined whether the treatment with cytokines 
and mitogens might induce Q5 ~ transcription. All factors 
tested were able to induce Q5 k gene expression in 
primary mouse spleen cell cultures and to increase the 
expression i  established cell lines. Thus, Q5 k message 
can be readily induced as a result of cell activation. 
Perhaps adirect or indirect hormonal influence is respon- 
sible for Q5 k expression i  the uterus of pregnant mice, 
whereas the Q5 k expression in the spleen of thymoma 
bearing animals could either be due to the presence of a 
second tumor in the mouse (perhaps leukemic ells), or 
simply to the status disease. 
Evidence is accumulating for a nonimmunological 
function of Mhc class I antigens, and it has been proposed 
that the nonpolymorphic class I molecules might play a 
role in morphogenesis and cell-to-cell interaction i  em- 
bryonic development, based on the finding of Warner and 
co-workers (1987), that preimplantation cleavage rate is 
controlled by a gene of the Qa-2 region. The recent study 
by Zijlstra and co-workers (1990), showing that mice 
unable to express the/32m gene develop normally, argues 
strongly against an essential influence of class I molecules 
in embryonic development, and also against an important 
nonimmunological function of these antigens. Although 
evidence has been presented that/32m is not required for 
cell surface expression of some class I antigens [shown 
for H-2D b by Allen and co-workers (1986), and for an 
HLA class I-like antigen by Schnabl and co-workers 
(1990), no function could be assigned to these heavy 
chains. Moreover, the 13:m-less H-2D b antigen was not 
recognized as alloantigen. Since the function of 
nonclassical H-2 class I molecules remains obscure, and 
does perhaps not depend on cell surface expression and 
on association with 132m, it is still formally possible that 
a Q5 k molecule could function in/32m negative mice. 
Several reports indicate that Mhc class I molecules in- 
teract in a possibly locus and allele-specific manner with 
a variety of cell surface proteins (Kittur et al. 1987; 
Sharon et al. 1988; Solano et al. 1988; Burlingham et al. 
1989). Particularly, H-2 class I antigens were shown to 
control the expression and function of the insulin receptor 
(Hansen et al. 1989; Stagsted et al. 1990). Current 
evidence indicates that complex formation with 
/32-microglobulin might also be necessary for these in- 
teractions. Recently a more general nonimmunological 
function of Mhc class I molecules has been suggested in
the control of the regulation of hormone receptors upon 
activation by their corresponding li ands (Stagsted et al. 
1990). Thus, quantitative or qualitative changes of class 
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I expression in tumor cells could contribute to the 
transformed phenotype via the regulation of receptor 
activity. Therefore, it is still conceivable that a Q5 k gene 
product might influence both morphogenesis and cell- 
to-cell interaction during embryonic development, aswell 
as cell growth and differentiation i the adult mouse. 
Recent data showed that the DNA binding subunits of 
NF-kB (p50) and KBF 1 are identical and display sequence 
homology with rel oncoproteins and the Drosophila dorsal 
gene (Ghosh et al. 1990; Kieran et al. 1990). The binding 
characteristics of p50 and KBF 1 are indistinguishable, but 
differ from those of the NF-kB and v-rel contact points 
on the Mhc class I site (Kieran et al. 1990). NF-kB-like 
v-rel contacts the four G residues of the palindrome site, 
but the external G is less critical than the following three. 
Gel shift analysis with the Q5 k motif revealed, that in 
contrast to the results published for the conserved perfect 
palindrome of the H-2Kb/HLA-A2 promoter, the asym- 
metrical Q5 k site with one differing nucleotide (TAGG- 
GATTCCCCA) seems to bind only NF-kB. These results 
were confirmed by competition analysis with purified 
KBF1 and NF-kB, indicating that the constitutive factor 
KBF1 binds with much lower affinity to the Q5 k motif 
than to the classical sequence. Thus, for constitutive factor 
binding, all four G residues are critical, and this might 
explain that the nucleofide xchange in the external G 
position (G-A) of the Q5 k promoter prevents KBF1/ 
H2TF1, but not NF-kB binding to this site. Although it 
has not been shown so far that his region is also important 
in the regulation of the Q5 k gene, the restricted binding 
activity of the Q5 k fragment might account for the 
expression data described above, where most adult issues 
have no constitutive Q5 k expression, and a significant in- 
crease can be observed after induction, possibly mediated, 
at least in part, by NF-kB. A similar situation has been 
described for the QIO gene (Handy et al. 1989), where 
a two nucleotide difference (TGAGGACTCCCCA) in 
this motif is responsible for the loss of constitutive 
expression. 
However, the presented binding affinity studies of the 
Q5 k motif cannot necessarily explain the activity of the 
Q5 k gene in embryonic, juvenile, and transformed 
tissues. It would be highly interesting to investigate a 
possible influence by the oncogenic members of the rel 
related protein family on tumor associated Q5 k induc- 
tion. Additional regulatory sequences, which also might 
be of essential importance for Q5 k regulation, also con- 
tribute to class I gene expression and therefore must be 
included in further studies focusing on the in vivo situation 
and on functional data. Comparison between protein- 
DNA interaction in gene expressing vs non-expressing 
tissues, embryonic vs adult tissue, methylation pattern 
analysis correlated with gene activation or inactivation, 
will be necessary to understand the complex regulatory 
system. 
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